Lightrock Netherlands B.V. Takes $5.19 Million Position in Envista Holdings Co. (NYSE:NVST)

Lightrock Netherlands B.V. bought a new stake in shares of Envista Holdings Co. (NYSE:NVST) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 267,900 shares of the company’s stock, valued at approximately $5,193,000. Envista makes up 1.8% of Lightrock Netherlands B.V.’s portfolio, making the stock its 26th biggest position. Lightrock Netherlands B.V. owned about 0.16% of Envista as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in NVST. Nuance Investments LLC lifted its stake in shares of Envista by 4.4% during the third quarter. Nuance Investments LLC now owns 7,346,534 shares of the company’s stock worth $145,168,000 after purchasing an additional 308,221 shares in the last quarter. Clarkston Capital Partners LLC lifted its position in Envista by 0.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 4,347,300 shares of the company’s stock worth $85,903,000 after acquiring an additional 17,085 shares in the last quarter. Franklin Resources Inc. boosted its holdings in Envista by 26.5% in the 3rd quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company’s stock worth $78,480,000 after acquiring an additional 830,861 shares during the period. Pacer Advisors Inc. grew its position in Envista by 22.2% in the third quarter. Pacer Advisors Inc. now owns 3,529,827 shares of the company’s stock valued at $69,749,000 after acquiring an additional 642,401 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Envista by 2.5% during the third quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company’s stock valued at $57,233,000 after purchasing an additional 71,435 shares during the period.

Analyst Upgrades and Downgrades

NVST has been the topic of a number of recent analyst reports. Stifel Nicolaus boosted their price objective on shares of Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Jefferies Financial Group increased their price target on Envista from $20.00 to $22.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Morgan Stanley raised their price objective on Envista from $19.00 to $20.00 and gave the company an “equal weight” rating in a research note on Thursday, February 6th. Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 31st. Finally, Mizuho initiated coverage on shares of Envista in a research report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $20.21.

Envista Trading Down 0.0 %

Shares of NVST opened at $21.24 on Tuesday. The company has a quick ratio of 1.77, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The firm’s 50 day moving average is $19.94 and its 200-day moving average is $19.20. Envista Holdings Co. has a 12-month low of $15.15 and a 12-month high of $23.06.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, sell-side analysts anticipate that Envista Holdings Co. will post 1.06 earnings per share for the current year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.